Ammar Al-Chalabi is a Clinician Scientist at King’s College London. His research focuses on causes, modifiers and potential treatments for ALS. He co-leads the UK Motor Neuron Disease Research Institute, chairs the International Symposium on ALS/MND, and is a National Institute for Health Research Senior Investigator. His work has been recognized by multiple prizes, including the Forbes Norris Award from the International Alliance of ALS/MND Associations, the Healey Center International Prize for Innovation in ALS, the Sheila Essey Award from the American Academy of Neurology, a Gold National Clinical Excellence Award, and early in his career, the Charcot Young Investigator Award from the MND Association.